FibroGen, Inc. (FGEN)
NASDAQ: FGEN · IEX Real-Time Price · USD
+0.080 (7.55%)
Jul 16, 2024, 4:00 PM EDT - Market closed

FibroGen Revenue

FibroGen had revenue of $167.49M in the twelve months ending March 31, 2024, with 44.30% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $55.90M with 54.59% year-over-year growth. In the year 2023, FibroGen had annual revenue of $147.75M with 4.99% growth.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
113.40M USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Dec 31, 2023147.75M7.02M4.99%
Dec 31, 2022140.73M-94.58M-40.19%
Dec 31, 2021235.31M58.99M33.46%
Dec 31, 2020176.32M-80.26M-31.28%
Dec 31, 2019256.58M43.62M20.48%
Dec 31, 2018212.96M81.96M62.57%
Dec 31, 2017131.00M-52.19M-28.49%
Dec 31, 2016183.19M2.36M1.31%
Dec 31, 2015180.83M43.23M31.41%
Dec 31, 2014137.60M35.43M34.68%
Dec 31, 2013102.17M36.24M54.96%
Dec 31, 201265.93M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
So-Young International 209.20M
FONAR 102.72M
Omega Therapeutics 4.94M
Sagimet Biosciences 2.00M
VistaGen Therapeutics 1.06M
Oramed Pharmaceuticals 674.00K
Zentek 21.92K
Revenue Rankings


More News